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INTRODUCTION
Cancer chemotherapy dates back almost to the beginning of the history
of medicine. Its systematic and substantial development, however, had to
await the recognition of the cellular nature of neoplasms, the growth of
experimental oncology and the general principles of experimental therapeu-
tics. Less than six decades have elapsed since the most recent of these
events and in this period thousands of chemicals, both synthetic and natural
materials, have been tested in dozens of ways against different experimental
tumors. Although these efforts have so far yielded a small number of agents
of proven clinical value against cancer in man, they have led to the accumu-
lation of an extensive body of information which has contributed significantly
to our knowledge in cancer research.
The present study, devoted to the preclinical screening of a newly
synthesized, substituted phenanthrene derivative against Sarcoma 37 in mice,
is an attempt to explore the possibility of finding an agent of clinical
value. In the following pages a study on the histopathologic changes asso-
ciated with the effects of 3,6-diacetate of 9,10-diethylphenanthrene on
Sarcoma 37 is described. For purposes of comparison, the parent compound,
diethylstilbestrol dlacetate, was included in the study.
REVIEW OF LITERATURE
According to a recent review by Plattner (1964) it was about 100 years
ago that Lissauer (1865) first used potassium arsenite in the treatment of
two cases of leukemia. A long hiatus ensued during which many drugs were
tried, but nothing of importance was found. In the early 1940' I estrogens
were used in metastatic prostatic cancer, and both sex hormones were given
to patients with advanced breast cancer. The above author (Plattner, 1964)
indicated that a clinical report on urethane appeared in 1946, but after a
period of use in chronic leukeraias and multiple myelomas it had been largely
superceded by other drugs. The author further stated that a major landmark
was the first report on the polyfunctional alkylating agents presented by C.
P. Rhoads shortly after the end of World War II. Since then a number of com-
pounds, related to nitrogen mustard, which have proved more acceptable in
certain situations have been described; these include triethylenemelamine,
chlorambucil, triethylene thiophosphoramide, busulfan, and cyclophosphamide.
In rapid succession the folic acid antagonists, the adrenal corticosteroids,
and 6-mercaptopurine became available, and the accelerated pace of discovery
heralded a bright future.
Plattner (1964) stated that since 1954 the major drugs which have been
found to be of practical value include 5-fluorouracil, 0,P-DDD (1,1-dichloro-
2-(o-chlorophenyl)-2-(p-chlorophenyl)ethane), and the vinca alkaloids,
vinblastine and vincristine. Compounds of unproved value include the
colchicine analogues, mitomycin C, methylglyoxalbis (guanylhydrazone, methyl-
GAG), hydroxyurea, methyl hydrazine (N-isopropyl-a-(2-methyl hydrazino)-p-
toluamlde), cystosine arabinoside and quinacrine.
Plattner also noted that cancer chemotherapy at present has come to fall
in the following four broad groups of compounds: alkylating substances, anti-
metabolites, antibiotics and alkaloids, and hormones and miscellaneous
compounds.
Hormone Therapy
Huggins et al. (1941) observed that hormones are significant factors in
the etiology of cancer, Its prevention and its treatment. The treatment of
mammary cancer by endocrine methods rests on the concept of hormonal depend-
ence, which characterizes many of these cancers. It has been learned that
the growth of several cancers, including certain carcinomas of the breast,
can be stimulated or inhibited by the administration or withdrawal, respec-
tively, of appropriate endocrine substances. Beatson in 1896 made a highly
important discovery when he found that removal of ovaries caused regression
of breast cancer in women. This classic work was done before there was any
concept of hormones. Many hormonal methods, since then, have been employed
for the treatment of breast cancer and prostatic cancer.
Estrogens, originally regarded as important factors in the development
and growth of breast cancer, were first demonstrated by Badger et al. (1942)
to have an inhibitory effect on established lesions as well. This challenged
the earlier concepts and provided impetus to a more thorough investigation.
Nathanson (1944) reviewed the clinical evidence relating the incidence of
cancer of the breast to age, early castration, and menopause and discussed
the first attempts with hormone therapy. At about that time the first data
on estrogen therapy of inoperable carcinoma of the breast appeared. Since
then large series have accumulated. Haddow et al. (1944) demonstrated the
regression of prostatic cancer after administration of estrogens. The
authors had also administered phenolic estrogens to a series of patients
with advanced cancer; the estrogens were triphenylchloroethylene, triphenyi-
methylethylene and stilbestrol. Nathanson (1946) stated that since then a
considerable number of natural and synthetic estrogenic preparations have
been utilized and by far the largest experience has been with diethylstil-
bestrol; but comparable results have also been obtained with most of the
other preparations.
Contrary to the expectations of hormonal therapy, Huggins et al. (1941)
for the first time noted that the patients who had received estrogen treat-
ment for eight to 23 days against prostatic cancer, developed small, palpable
areas of subareolar breast tissue. Nathanson (1946) described the effect of
stilbestrol on advanced cancer of the breast. He stated that stilbestrol may
exert an initial beneficial but temporary effect. The effect on metastases
was open to question. The favorable response was confined to older women and
the mechanism of action was not clearly understood. Taylor et al. (1948)
observed that the only clearly determined factor influencing the response of
the patients with breast cancer was age. Persons of advanced age responded
the best. Bnerson et al. (1949) made histological studies on biopsies and
whole breast specimens from patients with breast cancer treated with estro-
gens. The consistent changes were replacement of tumor tissue by fibrous
tissue. In the early stages of regression necrosis of tumor cells accompanied
fibrous proliferation. Herrmann et al. (1949), in the course of therapy with
diethylstilbestrol, observed reactions associated with hypercalcemia and
renal insufficiency in patients with breast cancer.
Stilbestrol has been the estrogenic preparation most widely used in the
treatment of prostatic cancer. Nathanson and Kelley (1952) indicated that
there was much disagreement about optimal dosage of the estrogens in the
treatment of prostatic cancer. The authors described the side effects of
estrogen administration in the male as loss of sexual power, shrinkage of the
penis, excessive weight gain and painful enlargement of the male breast even
to the extent of bilateral cancer. In some cases treatment had to be aban-
doned because of the intolerable side effects. The authors also described
the side effects of estrogen administration in the treatment of breast
cancer. They observed enlargement of the breasts, tenderness of the nipples,
deep pigmentation of the nipple and areola, uterine bleeding in patients over
sixty which was frequent but not severe and incontinence, which was one of
the most distressing symptoms. Kennedy et al. (1953) observed that hyper-
calcemia was a potential complication during estrogenic hormone therapy of
patients with advanced breast cancer.
Hormone therapy with estrogens was gradually discontinued in the follow-
ing years because of the undesired side effects. In search of compounds
which may be inhibitors of cancer, it thus became essential that the compound
should have no or very little estrogenic activity. Knoche and Gawienowski
(1962) proposed investigation of 3,6-derivatives of 9,10-diethylphenanthrene
derived from diethylstilbestrol by ultraviolet irradiation. The authors had
made a study on these compounds which indicated that 3,4,5,6, 12, 13-hexahydro-
3,6-dioxo-9,10-diethylphenanthrene (DEP-DK) and 3,6-dihydroxy-9,10-diethyl-
phenanthrene (DEP-DH) had l/150th of estrogenic activity of diethylstilbestrol.
The present study was based on this investigation to determine the effect of
a related phenanthrene derivative obtained by ultraviolet irradiation of
diethylstilbestrol on mouse tumor transplants of Sarcoma 37 and also its
estrogenic activity, if any.
The Effect of Hormones on Mouse Tumors
Gardner (1939) observed that intrinsic factors other than estrogens
played a significant role in mammary carcinogenesis in mice, and in some
strains of mice these intrinsic factors were largely dominated by the effects
of estrogens administered for long periods. Bittner (1941) indicated that
the administration of estrogenic hormones often resulted in the induction of
mammary tumors in mice which had an inherited susceptibility for spontaneous
tumors and an active milk influence. He showed that tumors were not induced
in any animal which had been nursed by females of strains which had low
incidence of spontaneous tumors, and suggested that by foster nursing it
should be possible to determine if the influence in the milk was active or
inactive in mice of any strain. The above author also observed that foster
nursing did not influence the genetic susceptibility of an individual for the
development of spontaneous mammary tumors. Allen et al. (1941) observed that
after extended treatment with high doses of estrogen, carcinomas of the
uterine cervix had appeared in 15 of 24 mice. He further showed that genetic
factors involved in mammary cancer seemed to have little influence as deter-
mining factors in cancer of the cervix uteri.
Gardner (1941) found that tumors of the adrenal glands arose in 13 of 15
ovariectomized mice of an early generation of the NH strain. These adrenal
tumors were associated with evidence of estrogenic stimulation as determined
by the condition of the uteri and mammary glands. The uteri showed cystic
glandular hyperplasia and the vaginal epithelium was thickly stratified
although not cornified. Jones (1941) observed that injections of testoster-
one propionate in virgin female mice of C H strains from the second to
twelfth month of life lowered the incidence of spontaneous mammary gland
tumors but did not inhibit growth of mammary gland tumors once they had
reached macroscopic size. Bittner (1942) determined that for the development
of mammary carcinomas in virgin and breeding females three factors had to be
present and active: an active mammary tumor milk influence which was gener-
ally transferred by nursing; an inherited susceptibility to the development
of spontaneous mammary tumors; and a hormonal stimulation of the mammary
tissue resulting in growth suitable for the cancerous change. He further
demonstrated that the mice with high incidence were the C H and A strains;
the strains with lew incidence were the C57 and C strains of mice. The
above author further indicated that the administration of estrogenic hor-
mones produced mammary tumors in males and females from strains of mice with
the active milk influence. The induced incidence was usually higher in
females than in males and the stimulation produced by large amounts of
estrogenic hormones could overcome the threshold of genetic nonsusceptibility
in the presence of an active milk influence.
Ifeiman (1943) observed that progesterone inhibited the growth of the
adenomatous portion of spontaneous rat mammary fibroadenoma. Shrinkage was
followed by fibrosis. He also Indicated that 18 mg. of progesterone did not
interfere with the stimulating effect of 2.5 mg. of estrogen. Comparative
studies were made by Howard et al. (1944) on the effectiveness in inhibiting
the growth of implanted sarcoma 180 by the use of three hormones; estrone,
diethylstilbestrol and progesterone. In certain strains estrone was found
effective both in males and females whereas diethylstilbestrol was effective
in females only. In certain substrains having a high incidence of spontane-
ous tumor these estrogens were not effective unlike the low incidence sub-
strains which showed beneficial results from the administration of estrogen.
The author emphasized that the milk factor was involved in resistance to
tumor growth.
The action of diethylstilbestrol was investigated by Ludford et al.
(1947) on ten different transplantable mouse tumors In mice of four inbred
strains. On these tumors stilbestrol showed no specific inhibition of growth.
The author emphasized that the genetic constitution was a significant factor
in determining sensitivity to the toxic action of stilbestrol. Pan et al.
(1948) observed that 4 of 10 estrogen-treated hybrid mice (C-H females X PM
males) that tolerated the treatment more than 200 days had carcinomas of the
uterine cervix or vagina.
Vaginal assays of estrogenic activity were performed by Trentin (1950)
on groups of 20 mice. Graded doses of estrogen were given. The minimum dose
of estradiol benzoata giving full cornification in approximately 50% of the
animals varied from 0.06 to 0.27 micrograms. The author showed that the
presence or absence of milk factor, obtained by foster nursing did not alter
vaginal sensitivity to estrogen.
Bittner (1952) presented experimental data on the transmission of a
spontaneous mammary tumor by males to females, which usually was considered
to be transferred exclusively by females in the milk. He showed that the
infected female could become cancerous or remain noncancerous, but that they
transferred the agent in their milk to their progeny which then had a high
incidence of mammary tumor. The agent for mammary cancer was recovered from
the mammary tumors that developed in either infected females or their
progeny.
According to Shapiro (1952), the beneficial response of certain human
malignancies to stilbestrol therapy had warranted numerous studies to find
a laboratory neoplasm which would similarly respond. Most of them were
unsuccessful, until Sarcoma 180 was utilized. The author found that diethyl-
8tilbestrol inhibited the growth of the 755 mammary adenocarcinoma in C57BL
mice and the combination of 8-azaguanine and stilbestrol had a striking
carcinostatic effect upon this tumor. This same author had shown that the
weight loss induced by stilbestrol in the experimental animals was reduced to
insignificant levels by addition of testosterone without affecting carcino-
static activity. He further emphasized that a proper genetic background was
the only factor responsible for the effectiveness of stilbestrol in mice.
Bilateral intraocular transplants of an adrenal cortical tumor from a CE
mouse were made by Browning et al. (1959) in intact and castrated male and
female CE/BALB/C hybrids. Various experimental groups were treated with
progesterone, estrogen and testosterone. In castrated males progesterone
accelerated growth, estrogen moderately slowed growth, but estrogen with
progesterone markedly slowed growth, and testosterone completely inhibited
it.
The effects of estrogens were studied by Angrist et al. (I960) with and
without foreign body on squamous metaplasia of the bladder of rats maintained
on a low vitamin A diet. Estradiol increased the degree of metaplasia in the
bladder when combined with vitamin A deficiency and/or foreign body stimula-
tion. Svaboda (1961) observed the effect of long term absorption of stil-
bestrol on the incidence of skin tumors induced by 3-methylcholanthrene and
the neutral fraction of tobacco tar. The incidence of the carcinoma in the
methylcholanthrene-plus-stilbestrol group was 39%, whereas in the methyl-
cholanthrene-only group the incidence was 17Z. Mammary tumors were induced
by Sternatal et al. (1963) with 20 mg. of 7,12-dimethylbenzanthracene. Sub-
sequent adrenalectomy-ovariectomy and hypophysectomy performed within 10 to
20 days after tumors were first detected resulted in tumor regression in all
the animals. Estrogen administration reactivated tumor growth after adre-
nalectomy-ovariectomy but not after hypophysectomy showing the dependency of
estrogen stimulation upon presence of the pituitary gland.
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Sarcoma 37
The original tumor from which Sarcoma 37 was derived was a spontaneous
adenocarcinoma, designated Carcinoma 37, that appeared in the thoracic region
of an old female mouse of the Imperial Cancer Research Fund Stock. The tumor
was resected on September 25, 1906, but recurred shortly thereafter, and the
mouse was killed on November 22, 1906. The origin and early transplant
generations of Carcinoma 37 and its transformation to an anaplastic tumor
were described by Haaland (1908) and by Bashford (1911). The original tumor
as described by Haaland was composed of acini and solid masses of cells with
some of the acini containing secretory material. The stroma was delicate in
some areas and abundant and cellular in others. The early generation trans-
plant tumors were similarly composed chiefly of acini and solid masses of
cells in varying proportion, but some showed cystadenomatous structures lined
with papillary excrescences. Forty to 50 percent of the transplants grew
successfully, beginning with the second transplant generation. Some sublines
of subsequent generations continued to reproduce the pattern of carcinoma;
ethers eventually came to resemble a sarcoma. This sarcomatous transformation
occurred several times in descendants of a series of transplanted tumors.
The transformation from carcinoma to sarcoma was a gradual process in trans-
plants propagated over a period of 5 to 18 months after the initial trans-
plantation of Carcinoma 37. Once the sarcomatous pattern was firmly estab-
lished in all parts of the transplantable tumor, the growth did not revert
to a carcinoma In any instance. Haaland (1908) in describing the transforma-
tion to sarcoma observed that the connective tissue stroma became more
cellular and increased in quantity. Broad bands of atypical spindle-shaped
cells appeared in the stroma, and these in turn were replaced by atypical
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polymorphous cells considered to be the sercomatous component. Necrosis of
the epithelial portion of the tumors appeared more frequently. With the
introduction of the sarcomatous element, the tumors were interpreted as being
of mixed type. Coincident with these changes in morphology, the growth rate
was increased, iletastases found in the lungs and elsewhere were either
carcinomatous, sarcomatous, or mixed in appearance. Eventually, in most
instances the carcinomatous elements were entirely replaced by sarcoma. A
tumor of one of the sublines that contained short, spindle-shaped ceils for
several generations finally became stabilized as a polymorphous-call sarcoma.
It was this tumor that later became known as Sarcoma 37. Although Sarcoma 37
grew successfully in 90 to 100 percent of hosts inoculated, it frequently
regressed. The tumor grew rapidly, invaded tissues adjacent to it, and
developed central necrosis as early as ten to fourteen days following trans-
plantation. Metastases were found in the lymph nodes, lungs, liver, spleen,
myocardium, and kidneys.
Although not strain specific, the transplant tumor has been observed to
grow better in some strains of mice than in others. Leiter and Kline (1953)
described their observations on the growth and regression of Sarcoma 37 in
about 2000 mice of 12 strains. According to these authors, the tumor grew
progressively without regression in more than 99 percent of the BALb/C,
DBA/2, ABC, ZBC and (BALE xA)F
l
mice (formerly CAF ) in which it was trans-
planted. Regression rates of 42 to 78 percent were observed in C h, C57BL,
CF, CFW, NIH-B.S., and NIH-Reg. mice. The Sarcoma 37 transplants grew for
a week or ten days before the signs of regression appeared.
According to Stewart et al. (1959) Sarcoma 37 has been used extensively
to evaluate the effectiveness of chemotherapeutic agents. Ihe tumor is
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valuable for such work, due to its successful transplantabillty and Its rapid
growth in mice of many strains. Moreover, transplants become richly vascular-
ized as early as five days after transplantation, and the untreated tumor
shows little degeneration and necrosis within the first eight or ten days.
Peters et al. (1946) during the first screening in tumor bearing mice
described the following compounds to have yielded microscopic evidence of
damage to Sarcoma 37: Cephalin hydrochloride; carydine hydrochloride; l-(p-
methoxyphenacyl)-3-picoliniura iodide; 2-phenacylisoquinolium iodide; pro-
flavine and d-tubocurarine chloride. The microscopic evaluation was based
on mitotic activity of the tumor ceils and necrosis. Diller (1947) observed
that 0.01 Dig. of Serratla marcegcens polysaccharide in a volume of 0.1 ml. of
sterile saline when given intraperitoneal ly produced nuclear damage to trans-
planted mouse Sarcoma 37 cells. Maximum destruction was attained at six
hours. Mitotic division of tumor cells was inhibited for three days follow-
ing treatment. MacCardle and Downing (1947) found that N-acetyliodocolchinol
methyl ether attacked Sarcoma 37 by arresting mitoses; necrosis followed.
Another compound, podophyllin, was described as having induced cell damage
throughout the tumor with marked hemes tasis and vascular damage.
In Swiss mice bearing Sarcoma 37 transplants, it was demonstrated by
Creech et al. (1948) that passive immunization with the antibody containing
fractions toward the P-3 type polysaccharide from the G. W. strain of
Sarratia marcescens, prior to the administration of relatively large doses
of that polysaccharide, definitely decreased the mortality rate without
interfering significantly with the tumor-necrotizing action of the polysac-
charide. Balkin et al. (1949) reported the effect of a single intraperi-
toneal injection of one ml. of a preparation containing about 285 million
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lyaed Trypanosoma cruzt organisms and the effect of six such dally Intra-
peritoneal injections on Sarcoma 37. No gross evidence of any effect was
observed. Histologic studies revealed no tumor damage. Leiter et al. (1949)
found that a number of compounds structurally related to podophyllotoxin
showed little or no activity against Sarcoma 37. Leiter et al. (1950) later
observed that podophyllotoxin, alpha-pel tatin, and beta-peltatln were highly
potent against Sarcoma 37. The minimum effective dose for a single sub-
cutaneous Injection was two micrograms per gram of body weight and the tumor
damage was observed grossly six hours after injection.
Flnkelstein et al. (1951) reported that multiple doses of 8-azaguanine
produced a definite inhibition of growth and extreme cellular damage of
Sarcoma 37. Gross tumor damage was noted within two to six hours, with
extensive morphological damage occurring 24 hours after a single large dose
of 8-azaguanine. These authors also observed that the drug was not completely
destructive to this tumor as typical morphology of the tumor was seen on
cessation of therapy. Kidder et al. (1951) observed that Sarcoma 37 in C57
black mice was not inhibited by the administration of 8-azaguanine.
The finding that methylation of the seven-membered C-rlng in colchicine
generally conferred higher potency against Sarcoma 37 in comparison with the
unmethyluted analogs was reported by Leiter et al. (1952). These authors
also observed that the methylated compounds were less potent than the unmeth-
ylated when the C-ring was a slx-membered aromatized one. Ninety-two
arsenicals were examined in over 3000 tumor bearing mice by Leiter et al.
(1952) for potency in damaging Sarcoma 37 following a single subcutaneous
injection. The compounds were aliphatic and aromatic derivatives containing
pentavalent or trlvalent arsenic. A dose near maximum tolerated was required
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for production of tumor damage with all of the active compounds. In investi-
gations with the 14 amide derivatives of colchicine, it was found by Leiter
et al. (1952) that colehiclneamlde was the only compound which gave a ratio
for maximum tolerated dose per minimal effective dose considerable greater
than that of colchicine (approximately 20 and 2 respectively).
Sixty-nine compounds were examined by Leiter et al. (1953) for potency
in damaging Sarcoma 37 following a single subcutaneous injection in CAF
mice. They included 30 biphenyl, 11 tropolone and 28 phenanthrene deriva-
tives and analogs. A dose near or above the maximum tolerated was required
to produce damage. The iso-forms of four potent colchicine derivatives,
colchicine, colchicine ethyl ether, colchicinamide, and trimethyl colchicine
acid methyl ether-d-tartrate, were all found to be inactive when tested in
an identical fashion by the same authors. These authors also emphasized the
importance not only of the nature of the substituents, but also of their
position in the C-ring of the colchicine molecule.
That 17 out of 27 derivatives of 1,3-diphenylpropylamine Induced damage
in Sarcoma 37 following a single subcutaneous injection was observed by Leiter
et al. (1953). Two of 10 derivatives of 2,3-dlphenylpropylamine induced
damage in the tumors, while 34 diphenylpropylenediamlnes and 26 diphenyl
alkanes were found to be inactive in producing tumor damage. The effect of
various hexoses upon Sarcoma 37 growing in tissue culture was investigated by
Rubin et al. (1954). Of the substances tested, a one percent equimolecular
mixture of D-glucose and ammonium chloride proved to be the most toxic for
tumor tissue. Leiter et al. (1955) recorded negative results with diphenyl-
ethylamines in producing damage in Sarcoma 37. Pradhan et al. (1956)
investigated the tumor-necrotizing effect of Serratia marcescens
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polysaccharide, pitressin, serotonin, amphetamine, histamine and acetyl-
podophyllotoxln-2-pyridinium chloride on Sarcoma 37. These authors observed
that the tumor damaging effect of nearly all the above drug3 was reduced by
the administration of cortisone, atropine, dibenamine, urethane or pento-
barbital sodium. However the tumor-necrotizing effect of acetyl-podophyllo-
toxin-2-pyridinium chloride was not impaired by any of the above drugs.
Injection of mice bearing transplanted Sarcoma 37 with living and killed
Candida species caused sloughing of the tumors; this was observed by Mankowski
et al. (1957). The authors found that following intravenous injection of
Candida auilliertaondi there was widespread distribution of the organisms in
normal tissues, as well as in tumors; no evidence of destruction in cells
other then those of the tumor was noted.
Havas et al. (1958) noted that the toxins obtained from several strains
of Streptococcus pyogenes and Serratia marcescens caused regression of
Sarcoma 37. The combined preparations caused higher regression rates than
streptococci alone. Serratia marcescens alone could also cause regression
of the tumor. Donnelly et al. (1953) reported tumor regression of Sarcoma
37 with mixed bacterial toxins. They described microscopic changes in the
tumor consisting of mitotic inhibition, pyknosis of nuclei, shrinkage of
cells, and cellular disintegration with hemorrhage. Grossly, hemorrhage
and eventual sloughing of the tumor were followed by healing and scar forma-
tion. It was concluded that bacterial toxins brought about tumor necrosis.
The polysaccharides obtained from higher plants induced hemorrhage end
necrosis in Sarcoma 37 as observed by Belkin et al. (1959). Some of the
plant polysaccharides that showed evidence of tumor damage were extracted
from burdock root, wild bryony root and meadow safron root. Diller et al.
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(1960) investigated the tumor damaging activity of the yeast polysaccharides
on Sarcoma 37. It was noted that hydroglucan had a greater oncolytic activ-
ity than zymosan. Diller et al. (1963) subsequently found that one mg. of
hydroglucan, when given intravenously, caused regression of 90 to 95 percent
of Sarcoma 37 in C_H mice. Lower percentages of regression of the tumor
followed administration of the same amounts of hydroglucan by the intra-
peritoneal, intramuscular, and subcutaneous routes.
Hirschberg (1963), in an exhaustive review of anticancer agents,
reported that of 79 compounds that were tested against Sarcoma 37 up to
1958, 55 had an inhibitory effect. These compounds included various groups
of nitrogen mustards, colchicine derivatives, steroids, ethylamines, purines
and miscellaneous hormones.
Phenanthrene Substitutes
One general difference between the physiology of normal and malignant
tissues as described by Furth (1953) is that tumor tissue is ordinarily
faster growing than normal tissue; there are proportionately more cells in
the process of division In the cancerous tissues. An attempt was made by
different investigators to utilize this property therapeutically. Dustin
(1934) observed that colchicine affects mitosis both in animal and vegetable
tissues. Brues et al. (1937) found that colchicine inhibits mitoses of the
tumor cells in the metaphase. This property of colchicine was exploited in
further investigation. It is well known that colchicine contains a phenan-
threne nucleus.
Turner (1939) investigated empirically compounds whose only apparent
relationship to colchicine was a phenanthrene nucleus with various
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substituents at different positions. The author tested 75 phenanthrene
derivatives in 1841 mice bearing transplanted sarcomas and 62 mice bearing
spontaneous carcinomas. No regression occurred in the mice having spontaneous
tumors but there was tumor regression in from one to 50 percent in mice bear-
ing transplanted sarcomas. Of the 75 phenanthrene variants, dihydrothebainone
hydrochloride, dihydro-des-N-methyldihydrothebainone, 9-aminomathyl phenan-
threne hydrochloride, dihydrothebainone, des-N-methyldihydrothebainone,
3[2-(diethylaraino)-l-oKoethyl] phenanthrene hydrochloride and 3-(2-piperidino-
1-oxoethyl) phenanthrene hydrochloride were found to be the most effective.
This same worker, however, stated that the tumor damaging activity could not
be satisfactorily associated with any specific chemical grouping. Turner
later (1943) tested a series of 43 phenanthrene derivatives and observed that
9-(2-methylaraino-l-oxopropyl)-phenanthrene hydrochloride, when given intra-
peritoneally in 74 doses of 2.5 mg. each, caused regression of mammary
carcinoma of spontaneous origin in Swiss mice. The percentage of regression
was not mentioned by the author.
Twenty-eight phenanthrene derivatives and analogs were examined by
Leiter et al. (1953) for potency in damaging Sarcoma 37 in CAF. mice. A
dose near or above the maximum tolerated dose was found to produce damage.
Of the 28 phenanthrene derivatives, l-methyl-5-(9-phenanthryl)-biguanide HC1,
phenanthraquinone, o-, m-, and p-phenanthroline were found to be active. Of
the above five compounds, the first two were true phenanthrene derivatives
and the remaining three compounds were analogs of phenanthrene in which two
heterocyclic rings replaced benzene rings. Of these only o-phenanthroline
was able to damage Sarcoma 37 at a dose of 30 micrograms per gm. body weight
which was appreciably below the maximum tolerated dose (80-100 micrograms
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per got. body weight).
Turner (1953), in subsequent studies on phenanthrene compounds, found
the following six compounds caused regression in Sarcoma 37: 2,9-aeetyi-
phenanthrene; 3-(2-araino-l-hydroxy-N-propyl) phenanthrene hydrochloride;
9-aminomethyl phenanthrene hydrochloride; 2-(3-diethyl amino) -1-oxopropyl)-
phenanthrene; ethoxy-4-acetylamino phenanthrene; and 3-(2-ethylaiaino)-l-
oxopropyi) phenanthrene hydrochloride. Of these six compounds it was indi-
cated that ethoxy-4-acetylamino phenanthrene had. the maximum activity. Five
mg. of the compound given in 13 doses in mice with Sarcoma 37 caused tumor
regression. The ratio between the siees of the tumor in treated mice and
the controls was 15.
Field et al. (1959) made an extensive study by testing 170 phenanthrene
derivatives for tumor-inhibitory effect on another mouse tumor, Sarcoma 180.
Eight of the compounds tested were observed to inhibit the growth of Sarcoma
180. The resulting tumors ware significantly smaller than control tumors (25
percent or more). The authors noted that no hydroaromatic phenanthrene
derivative was active nor was any derivative which carried a substituent in
the 2-position. All active compounds had substituents either in the 3-poei-
tion or meso-position, often in both. It was also observed that all active
phenanthrene derivatives were amines, in most instances tertiary amines.
Among the tertiary amines there appeared to be an optimum chain length of
five to eight carbon atoms in the alkyl groups attached to nitrogen. It was
also shown by the same investigators that no phenanthrene derivative could
induce reduction in tumor size greater than 35 percent. Histopathologic
studies revealed a decrease in mitotic figures and increased presence of
areas of necrosis. Pyknosis, karyorrhexis and karyolysis were observed in
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the tumor cells. The following phenanthrene derivatives were found to be
active in the above study: l-(9-phenanthryliaethyl arnino)-2-propanoi; 9-bromo-
3-(3-diamylamino-l-c«opropyl)-phenanthrene; (>chloro~3-(2-dihexylamino-l-
hydroxyathyl)
-phenanthrene; 3-C2-diamylaminc~l-hydroxyethyl)-phananthrene;
9-chloro-3-(2-dioctylamino-l-hydroxyathyl)-phananthrena; 9-chloro-3-(2-
diauylamino-l-hydroxyetnyD-phenanthranaj 3-(2-amino-I-chloroethyi)-phenan-
threne; and 9-bromo-3-<3-dihaxylamino-l-oxopropyl)
-phenanthrene. Tumor
regression with the above compounds ranged from 23. 5 to 35 percent. These
authors stated that five of the eight phenanthrene derivatives were bata-amino
alcohols and two were amino ketones. The most aetlve compound was 3-<2-amino-
l-chlorethyl)-phananthrene hydrochloride, a bata-aad.no chlorice with which
there was a maximum regression of 35 percent. It was indicated that the
enhanced activity of this compound was due to the analogy between this can-
pound and the nitrogen mustards. As in the case of nitrogen mustards,
replaceiaent of the chlorine in the above compound by an unreactive group
resulted in loss of biological activity; for example, it was shown tnat
3-<2-amino-l-mathoxyethyl)-phenanthrene hydrochloride was found to be inactive
against Sarcoma ISO.
Snoche and Gawienowski (1962), in a search for compounds which inui.it
cancer yet have very low estrogenic activity proposed investigation of 3,6-
derivatives of 9.10-diethylphenanthrene derived from diethylstllbestrol and
its derivatives by ultraviolet irradiation. They also observed that 3,4,5,6,
12,13-hexahydrc>-3,6-dioxo-9,10-dlethylphenanthrene and 3,6-diuydroxy-9,lG-
dlethylphenanthrene had minimal estrogenic activity comparea to the diethyl-
stilbestrol.
20
MATERIALS AND METHODS
Compounds Studied
Studies were made in collaboration with Sister Mary Grace Waring, Ph.D.,
Marymount College, Salina, Kansas, who prepared the compound and undertook
the toxicity studies and tumor transplantation. The compound, 3,6-dlacetate
of 9,10-diethylphenanthrene (DEP-DA), was prepared by a method originally
suggested by Banes (1961) and Hugelshofer (I960); it involved irradiation of
diethylstilbestrol by ultraviolet light to obtain the above mentioned
phenanthrene derivative.
For purposes of comparison, the 4,4-diacetate salt of the parent com-
pound, diethylstilbestrol (DES-DA) was also studied.
Tumor-susceptible C3H/HeJ Mice
Preliminary toxicity determinations and standardization of procedures
were performed on three to four week old, non-pedigreed white mice.
Mice of the tumor-susceptible C U/Hej strain were obtained from the
Jackson Laboratory, Bar Harbor, Maine. The offspring were used to maintain
the strain, for toxicity and tumor inhibition studies. Arrangements were
also made with the Jackson Laboratory to supply CgH/Hej randomized mice when
needed.
Sarcoma 37
Sarcoma 37 tumor was obtained from the Jackson Laboratory, Bar Harbor,
Maine, in DBA/ LI mice and immediately transferred to the C.H/Hej mice. Trans-
fer was accomplished by preparing a brei of the excised tumor material in
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Tyrode»8 solution (Harper, 1957) and injecting 0.2 ml. of this cell suspen-
sion subcutaneously in the right axillary region of the tumor susceptible
mice.
Determination of the Toxicity of the DEP-DA and DES-DA
The toxicity studies were deemed necessary since there \7ero no data
available on the newly-synthesized compound. Therefore, the directions given
in protocol 4, "Selection of dosages," Cancer Chemotherapy Report No. 25,
December, 1962, were followed in this experiment.
Preliminary studies were made by injecting into mice 0.2 ml. of the
vehicle in which the drug would later be administered in the toxicity
studies. The carriers used were corn oil and olive oil. Mice were divided
into the following groups.
Croup A. Corn oil injection: Three male and five female C H/Hej mice were
injected and an identical group was retained as controls.
Group B. Olive oil injection: Four male and four female CJH/Hej mice were
injected and an identical group was kept as controls.
Group C. Normal saline: Three male and three female C H/Hej mice were
injected and four male and four female mice were utilized as
controls.
Before injecting, the mice were shaved at the site of injection. The area
was wiped with a cotton swab moistened with lysol, then with 70 percent
alcohol. The injection was given subcutaneously in the thigh over the biceps
femoris muscle. After one week each mouse was anesthetized with ether. A
midline thoraco-abdominal incision was made; the area over the injection-
site was also incised to indicate where the injection was made. The brain
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was reiaoved. The mouse end Its brain were placed In a square of gauze,
tagged, and placed in 10% buffered formalin.
Only C
3
H/Hej female mice were used in toxicity studies on DEP-DA and
DES-DA. Injections, which were carried out at intervals of 0, 48, 72, and
96 hr, were made on the back of each mouse in such a way that the four points
of injection would make a square. Dosage was determined by calculating the
average weight of each group. Mice were sacrificed on the seventh day after
the last injection.
Group 1: Injection of DEP-DA in C. 2 ml. of corn oil was given et a rate of
46.6 rag, /kg. mouse. The raiee were 40-41 days old. Four mice were
used.
Group 2: Injection of DEP-DA in 0.2 ml. of corn oil was given at a rate of
96.5 rag. /kg. mouse. Mice were 39 days old. Four mice were used.
Group 3: Injection of DES-DA in 0.2 ml. of corn oil was given at a rate of
45.8 reg./kg. Mice wore 40-41 days old. Four mice were used.
Group 4: Injection of 0.2 ml. of corn oil only was given per mouse. Four
mice were used.
Studies with DEP-DA and DES-DA on Tumor Transplants
Tumor material was excised from donor mice and used to prepare a brei
in Tyrode's solution. Eighty C H/Hej mice, 36 * 3 days old, received 0.2 ml.
of the cell suspension subcutaneous ly in the right axillary region. The
mice in which the transplanted tumor material began to proliferate (77/80)
were divided into five groups, and were weighed by cages in order to determine
the appropriate dosage of the compounds to be tested. The DEP-DA and DES-DA
were dissolved in corn oil for this study. Five daily injections of the
compounds were made, starting the third day after tumor transplantation.
The groups of mice and their dosages were as follows:
Group |f Two-tenths of a ml. of a solution containing 33.5 mg./lO ml. of
DEP-DA was given to each mouse. At this rate each animal received
45 mg./kg. There were 16 mice in this group.
Group 2: Two- tenths of a ml. of a solution containing 67.0 mg./lO ml. of
DEP-DA was given to each mouse. At this rate every animal received
90 mg./kg. Sixteen mice made up this group.
Group 3: Two-tenths of a ml. of a solution containing 26.8 mg./lO ml. of
the DES-DA was given. Each mouse received the drug at a rate of
36 mg./kg. The group contained 16 mice.
Group 4: This group of 15 mice received 0.2 ml. of com oil only.
Group 5: These 14 mice received no injection other than the tumor.
Pathogenesis Study
Twenty-3ix mice of the C_ll/Hej strain were used in this study. Mice
were weighed before injection of the tumor. Two-tenths of a ml. of tumor
brei of Sarcoma 37 was then injected into each mouse. Five injections of
DEP-DA at the higher dose, i.e., 90 mg./kg., were made starting on the
fourth day post-tumor inoculation. Each day following tumor injection one
mouse was sacrificed for study. The weight of the mouse and the tumor
dimensions were recorded at the time of sacrifice. Tissues from these mice
were collected as before for histopathologic examination.
Preparation of Tissues for Histopathologic Examination
The mice from the toxicity studies and tumor-inhibition studies were
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observed carefully. They were sacrificed If they appeared to be at the point
of death and those which died were removed from the cages as soon as possible.
All mice were preserved In 10% buffered formalin as described In an earlier
section. Mice from both the toxicity studies and the tumor-inhibition
studies were later dissected and organs collected from them as follows:
1. Liver
2. Stomach with Pancreas
3. Anatomic divisions of small and large intestines
4. Spleen
5. Kidney8 with the adrenal
6. Testes with epididymis
7. Ovary and uterus
8. Lungs
9. Heart
10. Brain
11. Leg muscle
12. Piece of rib cage
13. Urinary bladder
14. Entire section of skin and muscle surrounding point of injection
15. Piece of tumor tissue
16. Any other tissue In the body where lesions were found grossly.
The fixed tissues were trimmed, embedded, sectioned and stained with
histologic stains. Hematoxylin and eosin were used on all tissues routinely;
special stains including VonKossa's, Wilder' s silver stain and periodic
acid-Schiff stain were also used to demonstrate calcification, reticulum
and mucopolysaccharides, respectively.
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RESULTS
Sarcoma 37
The tumor consisted of a solid mass of cells (Plate IV, Fig. 1)* inter-
spersed with small amounts of stroma. The tumor cells were round, slightly
elongated or occasionally pleomorphic and were closely packed. The cytoplasm
was basophilic and homogenous; the nuclei were round or oval. Mitotic
figures were numerous in the viable portions of the tumor (Plate IV, Fig. 2).
The tumor was quite vascular as represented by small blood vessels throughout
the substance of the tumor. A small amount of hemorrhage was noted in some
parts of the tumor. The host tissues, especially the subcutis and muscles of
the intercostal spaces, were infiltrated by the tumor cells and showed a
slight inflammatory reaction with proliferation of young fibroblasts and
hyperemic blood vessels.
Metastases were observed in the lung (Plate V, Figs. 1 and 2) and the
liver (Plate VI, Figs. 1 and 2). The former were considered to be hematoge-
nous since several single and multiple cell emboli were seen in interstitial
capillaries. In the latter case, metastasis occurred in one instance by
simple extension since the lesion was observed to be contiguous with the
primary tumor; the other instance appeared to be hematogenous.
The untreated tumor showed rapid growth with little degeneration and
necrosis within the first eight or ten days. Later the tumor outgrew the
vascular supply and became necrotic. Necrosis of the tumor cells was charac-
terized by pyknosis, karyorrhexis and karyolysis. Calcification was also
*
This plate and all subsequent plates are found in the Appendix.
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seen (Plate VII, Fig. 1) in the degenerated and necrotic area*. Hemorrhage
was consistently observed in the necrotic areas of the tumor. In the viable
portions of the tumor there was abundant reticulum (Plate VII, Fig. 2). The
degenerated tumor tissue was devoid of reticular fibres. In a number of
instances the tumor bearing mice had a splenomegaly with lymphoid hyperplasia.
Toxicity Studies
The carriers used for the administration of the phenanthrene derivatives
in the toxicity study were corn oil and olive oil. In the group of mice which
received corn oil the principal change noted was a granulomatous reaction
occurring in the skin at the site of injection. However, this change was not
consistent in all the mice. The olive oil in general, produced a lesser
reaction, the injection site being characterieed only by accumulations of the
oil in large subcutaneous spaces, which could be seen both grossly and
microscopically. Corn oil was chosen as the carrier for the drugs because
of the enhanced solubility of DEP-DA and DES-DA in it.
The mice which received DEP-DA at a rate of 46.6 mg./kg. were found to
have many tissue changes. The principal change was observed in the uterus
and consisted of endometrial hyperplasia (Plate VIII, Figs. 1 and 2). The
endometrium was thickened and showed an increased number of uterine glands,
most of which contained secretion. The blood vessels were found to be
hyperemic. There were no cystic changes. These findings were consistent
in all the mice receiving the above compound at that rate. The wall of the
urinary bladder was also thickened due to an increased depth of the lamina
propria and submucosal layer. The epithelial lining of the urinary bladder
was found to have a tendency towards squamous metaplasia (Plate IX, Fig. 1)
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but this was net well enough defined to say definitely, even though thicken-
ing of the bladder wall was consistent with every mouse in this group. The
thickening of the uterine horns and the urinary bladder, it should be noted,
could be seen at gross examination in most of the cases.
Another organ in which pathologic changes were observed was the kidney.
Coagulation necrosis of the tubules was predominant. The necrosis in most
of the cases was confined to the cortical region. In the rest of the organ
pyknosis was evident. The degenerative changes In tne kidney did not elicit
any Inflammatory reaction although some amount of congestion was observed In
almost every case. No visible lesions were associated with the adrenal.
The liver was grossly enlarged in almost all the mice which received
DEP-DA. Microscopically there was both cloudy swelling and hydropic degen-
eration seen in the cord cells; passive congestion was also observed. An
interesting finding on the hematoxylin and eosin stained sections of liver
was the presence of numerous, spherical, eosinophilic, refractile bodies,
located Intracellular^ for the most part, but occasionally seen extracellu-
larly. The bodies were neither PAS positive nor did they give a positive
result when examined under polarized light.
The lungs were invariably congested. It was presumed that this change
was principally due to the effect of ether that was used to sacrifice the
animals. In some Instances the brains were congested; this was also presumed
to be due to the method of euthanasia employed on these animals. Me lesions
were found in the gastrointestinal tract, pancreas, spleen, heart or skin.
In the second group of mice that received DEP-DA at a rate of 96.3 mg./
kg. the uterus was the primary site of pathologic changes. Grossly the
uterus was enlarged; microscopically, there was endometrial hyperplasia and
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cystic changes were seen In the endometrial glands of some uterine sections.
There was secretion in the uterine glands and the blood vessels were hypere-
mic. Another important change in the uterus was squamous metaplasia (Plate
IX, Fig. 2). Although in all the cases endometrial hyperplasia was a consist-
ent lesion, squamous metaplasia was seen in about 50 percent of the cases.
The changes in the liver were similar to those described for the lower dosage
of DEP-DA.
In the mice that received DES-DA at a rate of 45.8 mg./kg. the most
significant change occurred in the uterus which was grossly enlarged. There
was endometrial hyperplasia and also squamous metaplasia. Both the patho-
logic changes were consistent in the group. The wall of the urinary bladder
was also thickened.
Experimental Study With the Injections
of Tumor and Compound
The first group consisted of mice that received DEP-DA at a rate of 45
mg./kg. The principal microscopic changes observed were areas of hemorrhage
and necrosis In the tumor. Mitotic figures were reduced in the viable areas
of the tumor. Karyorrhexis, karyolysis and calcification were seen in the
necrotic areas of the tumor. Fibroblast proliferation in the tumor was not
marked. Grossly the tumor assumed a erateriform appearance with scab forma-
tion following the hemorrhage and necrosis (Plate I, Figs. 1 and 2) (Waring,
unpublished data).
The lungs were found to be congested with proteinaceous fluid in some
alveoli. In a few mice of this group metastases were seen in the lungs. The
uterine wall was thickened due to endometrial hyperplasia but it was not as
marked as that observed in the toxicity studies. The lamina propria and
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subroucosa of the urinary bladder was thickened. Coagulation necrosis was
seen in the renal tubules; pyknosis was generalized but with the exception
of a slight amount of congestion there was no other reaction. The liver was
found to be congested. No visible lesion was found in the gastrointestinal
tract, heart or pancreas. Lymphoid hyperplasia was observed in the spleen.
In the second group of mice which received DEP-DA at a rate of 90 mg./
kg*, the following pathologic changes were observed. Grossly, there was even
more shrinking of the tumor tissue than had occurred at the lower dosage of
DEP-DA (Plate II, Fig. 1). Microscopically, the primary change In the tumor
was an obvious decrease in the number of mitotic figures. Many areas of
hemorrhage and necrosis were seen, typified by karyorrhexis, karyoiysis,
and calcification. Fibroblast proliferation and compression of connective
tissue around the tumor were also observed. No metastasis was seen in any
of the examined organs. Congestion was noted in the lungs and liver. Coagu-
lation necrosis was observed In the renal tubules; pyknosis was a predominant
feature. The uterus was grossly enlarged; microscopically there was endo-
metrial hyperplasia. Unlike the toxicity studies, squamous metaplasia was
not seen in a single Instance; however endometrial hyperplasia remained a
consistent lesion. Similarly the wall of the urinary bladder was thickened.
No lesions were found in the brain, gastrointestinal tract, pancreas, or
heart.
The mice In group 3 received DES-DA at the rate of 36 mg./kg. Changes
comparable to those observed with DEP-DA occurred grossly (Plate II, Fig. 2).
Necrotic areas were seen in the tumor on microscopic examination along with
hemorrhage and fibroblastic proliferation. Karyorrhexis, karyoiysis and
calcification could be observed. In the viable portions of the tumor there
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were mitotic figures. Metastati3 was not observed. The uterus was enlarged
due to endometrial hyperplasia; the uterine glands contained secretion and
the blood vessels were hyperemic. The urinary bladder wall was thickened.
Coagulation necrosis was seen in the renal tubules. The liver was congested.
No visible lesion was found in the brain, gastrointestinal tract, pancreas
or heart.
Group number 4 consisted of mice that received only corn oil along with
the tumor. It can be seen in Plate HI, Fig. 1, that little change occurred
in the tumors of this group. Microscopically there were no significant
pathologic changes in this group, other than those associated with the tumor.
The tumor consisted of many viable areas characterised by numerous mitotic
figures. Hemorrhage and areas of necrosis seen in many cases appeared to be
the result of the tumor having outgrown its blood supply. Fibroblast prolif-
eration was minimal. Metastases to the lungs were observed in a few
instances. Lymphoid hyperplasia was seen in the spleen. Congestion was
noted in the liver and lungs. No lesions were found in the brain, gastro-
intestinal tract, pancreas, heart muscle or uterus.
The mice comprising group 5 served as tumor-injected controls (Plate
III, Fig. 2). The tumors in this group of mice had many viable areas with
numerous mitotic figures and anaplastic cells. Occasionally areas of
hemorrhage and necrosis were also observed that were due to the rapid pro-
liferation of the tumor cells beyond their nutrition. Metastases were seen
in the lungs. Infiltration of the rib cage was the rule in practically every
case. Lymphoid hyperplasia was seen in the spleen; in many cases spleno-
megaly was evident on gross examination. Congestion was found in the liver
and kidneys. No evidence of hyperplasia was found in either the uteri or
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urinary bladders. No lesions were found in the gastrointestinal tract,
pancreas, heart or brain.
PATHOGENESIS STUDY
1-3 days: At the site of tumor inoculation a mass of tumor cells was
demonstrable microscopically intermingled with numerous inflammatory ele-
ments (Plate X, Fig. 1). The blood vessels adjacent to the area of the tumor
cells were found to be hyperemlc. Early fibroblast proliferation was else
manifested by the host tissue. For the first two days no mitotic activity
was noted in any of the neoplastic cells nor was there evidence of infiltra-
tion. Within the tumor mass, cell debris was found which consisted of
disintegrated parts of the tumor brei.
Lymphoid hyperplasia was observed in the spleen; however, it was not
very marked. The lungs were congested. Post mortem changes that were
observed in the kidneys included coagulation necrocis of the proximal tubules
and pyknosis of other parenchymal cell nuclei.
4-6 days: On the fourth day post-tumor-inoculation the mice received
the first injection of the DEP-DA compound. By this time the tumor cells
had started proliferating as was evidenced by mitosis and infiltration into
the subcutis (Plate X, Fig. 2). There were numerous small blood vessels in
the tumor mass indicating that the tumor had established itself in the host
tissues. Adjacent to the tumor the blood vessels were hyperemic and there
was fibroblast proliferation. fly the sixth day the tumor was found to con-
tain necrotic areas in which pyknosis was prominent.
The lungs were congested. Postmortem changes were observed in the
kidneys as evidenced by coagulation necrosis and pyknosis; bacteria were
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found intravascular!)? in one instance. Lymphoid hyperplasia was detected in
the spleen. The uteri were found enlarged on gross examination; microscop-
ically endometrial hyperplasia was observed. The urinary bladder was
thickened due to an increase in the depth of the lamina propria and submucosa
and in one instance there was squamous metaplasia.
7-9 days: Extensive areas of necrosis were found in the tumor which
were characterized by pyknosis, karyorrhexis and karyolysis (Plate XI, Figs.
1 and 2). In the viable portions of the tumor the mitotic figures were
reduced in number. There were no areas of hemorrhage. At the periphery of
the tumor mass there was a slight reaction characterized by hyperemic blood
vessels and fibroblast proliferation.
The lungs were congested and occasionally there was interstitial thick-
ening. Lymphoid hyperplasia was noted in the spleen. Congestion was seen
in the liver. Endometrial hyperplasia and active glandular secretion was
found in the uteri. The pathologic changes in the kidney were those of post
mortem autolysis.
10-12 days: Many necrotic areas were found in the tumor which had
infiltrated into the subeutis and cutaneous muscle. Proliferation of fibro-
blasts was seen adjacent to the tumor. Mitotic figures were noticeably
reduced in the viable areas of the tumor.
The lungs were congested and showed interstitial thickening. The liver
was congested and in one instance micro-abscesses were found. Endometrial
hyperplasia was a consistent lesion in the uterus. The urinary bladder was
thickened due to increased lamina propria and submucosa. In a few instances
squamous metaplasia was also observed. The kidney showed post mortem changes,
13-15 days: The tumor contained large areas of necrosis and hemorrhage.
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There were also signs of calcification in a few instances but this was not
prominent. Mitotic figures were markedly reduced in the viable portions of
the tumor.
Lymphoid hyperplasia was observed in the spleen. The urinary bladder
was thickened and occasionally revealed squamous metaplasia. The uterus
was enlarged due to endometrial hyperplasia. The kidneys showed post mortem
changes.
16-26 days: Extensive areas of hemorrhage and necrosis were found in
the tumor. Calcification was also a prominent feature in the degenerating
tumor cells. On the seventeenth, eighteenth and nineteenth day small meta-
static tumor foci were observed in the lungs. This was rather contrary to
expectations since metastases were not observed in the tumor inhibition
studies with the higher dose of the DSP-DA.
The urinary bladder was thickenad and occasionally squamous metaplasia
was noted. Lymphoid hyperplasia was observed in the spleen. The uterus was
enlarged due to endometrial hyperplasia.
DISCUSSION
Hormone therapy with estrogens in patients with breast cancer has been
gradually discontinued because of undesirable side effects such as uterine
bleeding, incontinence and hypercalcemia; it has become essential that for
a related compound to be useful it should, in addition to inhibiting cancer,
have no estrogenic activity. Knoche and Gawienowski (1962) proposed investi-
gation of 3,6-derlvatives of 9,10-diethyl phenanthrene derived from diethyl-
stilbestrol and its derivatives by ultraviolet irradiation. Such a compound,
3,6-diacotate of 9,10-diethyl phenanthrene (DEP-DA) was synthesized by
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ultraviolet irradiation of diethylstilbestrol diacetate (DES-DA) (Waring,
unpublished data). The purpose ox the present study was to investigate both
the anti tumor activity and estrogenic activity of DEP-DA and compare these
actions with those of the parent compound, DES-DA,
Results of toxicity studies revealed that the new compound was estrogenic
and that its action upon the uterus was quite marked. The uteri of the mice
were enlarged on gross examination end histologic examination confirmed the
presence of endometrial hyperplasia. Another organ often involved was the
urinary bladder; the wall was thickened due to the increased lamina propria
and suboiucose. Occasionally squamous metaplasia cf the urinary bledder
epithelium was noted. These histopathologic changes were attributed to the
estrogenic activity of the DEP-DA. The findings were much like those of
Angrist et al. (1960) who observed squamous metaplasia in the urinary bladder
following prolonged estrogen administration associated with a study on
avitaminoses.
In the toxicity studies on the parent compound, DES-DA, the histopatho-
logic findings were similar, but more marked. On gross examination the
utevi were enlarged. Microscopically the lesions consisted of endaaetrial
hyperplasia and squamous metaplasia; the latter change was consistent in all
experimental mice in this group.
The antitumor activity of DEP-DA was characterized histologically by
extensive areas of necrosis in the tumor and a decreased number of mitotic
figures. Pyknosis, karyorrhexis, karyolysis and calcification were observed
in the tumor cells. The above findings were in agreement with Peters et al.
(1946) whose observations on damage to Sarcoma 37 with cephalin hydrochloride
were similarly baaed on decreased mitotic activity of the tumor cells and
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necrosis. It was observed that the most striking antitumor effect of the
phenanthrene derivative in the present study was its capacity to arrest the
mitotic activity in the tumor cells; these findings coincided with the obser-
vations of MacCardle and Downing (1947) with a colchicine compound and Don-
nelly et al. (1958) with mixed bacterial toxins used against Sarcoma 37.
In eontrast with the findings of Finkelstein et al. (1951), who observed
that multiple doses of 8-azaguanine produced reversible damage to Sarcoma 37
since typical morphology of the tumor cells was seen to return on cessation
of therapy, the DEP-DA apparently caused a more complete destruction of the
tumor cells for they did not show any tendency to recover normal morphology
following treatment. Necrosis of the tumor cells with cellular disintegra-
tion and calcification were observed along with fibroblast proliferation
adjacent to the areas of necrosis. The results obtained in the present study
were in agreement with Brues et al. (1937) and Turner (1939) who observed
that the phenanthrene nucleus might be responsible for the antitumor activity
of colchicine compounds. The results were also in agreement with Field et
al. (1959) who pointed out that all active phenanthrene compounds had sub-
stituents either in the 3-position or mesoposition and often in both.
In the comparative tumor studies in which DES-DA was used, antitumor
activity was characterized by areas of necrosis and reduced numbers of
mitotic figures in the tumor cells. Since the compounds had similar configu-
ration, this duplication of effect was not considered unusual. It should be
noted that thickening of the uterine wall due to endometrial hyperplasia was
consistently observed but without a single instance of squamous metaplasia as
had occurred in the toxicity study. No explanation was found for this. The
wall of the urinary bladder was similarly thickened due to increased lamina
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propria end sutxnucosa with a few Instances of squamous metaplasia; the find-
ings were not unlike those of the toxicity study on DES-DA. Gardner (1941)
and other workers observed endometrial hyperplasia on prolonged administra-
tion of estrogens but none reported squamous metaplasia in the uterus. How-
ever, Bittner (1941), Allen et al. (1941), Pan et al. (1948), Svaboda (1961),
and other workers induced mammary tumors and carcinomas of the cervix uteri
by prolonged administration of estrogens In mica.
The most significant change observed in the pathogenesis studies In
which the mice were treated with a higher dose of DEP-DA, was that the tumor
developed necrotic areas as early as the sixth day, i.e., three days after
the first injection of the drug. In contrast the untreated tumors took 10
days or more to develop necrotic areas in the normal course of their growth.
The 3,6-dlacetate of 9,10-dlethyl phenanthrene was shown to possess
antitumor activity principally evidenced by arresting mitoses in the tumor
cells. In spite of its estrogenic activity the new compound may prove to be
valuable on further investigation.
SUMMARY
Studies are reported on the effect of a newly synthesized compound,
3,6-dlacetate of 9,10-dlethyl phenanthrene obtained by ultraviolet irradia-
tion of diethylstilbestrol diacetate, against Sarcoma 37 in tumor susceptible
mice of the CgH/Hej strain. The compound is shown to possess a rather pro-
nounced antitumor activity which is demonstrated microscopically by extensive
areas of necrosis and hemorrhage and reduced numbers of mitotic figures in
the tumor cells; antitumor activity Is characterized primarily by the arrest-
ing of mitoses. The compound is also seen to possess estrogenic activity
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evidenced microscopically by endometrial hyperplasia in all experimental mice
with a few instances of squamous metaplasia in both the uterus and the
urinary bladder.
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APPENDIX
EXPLANATION OF PLATE I
Fig* 1. Mouse from Group 1 of the tumor inhibition study which
received DEP-DA at a rate of 45 mg./kg. Front view to show
hemorrhage and crateriform effect. Picture taken on four-
teenth day post tumor inoculation.
Fig. 2, Mouse from Group 1 of the tumor inhibition study, which
received DEP-DA at a rate of 45 mg./kg. Picture taken on
eighteenth day post tumor inoculation to show the height of
the tumor.

EXPLANATION OF PLATE II
Fig. I. Mouse from Group 2 of the tumor inhibition study, which
received DEP-DA at a rate of 90 mg./kg. Picture taken on
eighteenth day post tumor inoculation to show height of the
tumor.
Fig. 2. Mouse from Group 3 of the tumor inhibition study, which
received DES-DA at a rate of 36 mg./kg. Picture taken on
eighteenth day post tumor inoculation to show the size and
condition of the tumor for comparison with those that re-
ceived DEP-DA.

EXPLANATION OF PLATE III
Fig, I. Mouse from Group 4 of the tumor inhibition study, which
received 0.2 ml. of corn oil only. Picture taken on eight-
eenth day post tumor inoculation to show the height and
growth of the tumor.
Fig. 2. Mouse from Group 5 of the tumor inhibition study, which
received only the tumor. Picture token on eighteenth day
post tumor inoculation to show the growth and condition of
the tumor.

EXPLANATION OF PLATE IV
Fig, 1. Photomicrograph of a tumor from C„H/IIej control mouse which
received no compound. Solid mass of cells interspersed
with small amounts of stroma. The tumor is seven days
old. Hematoxylin and eosin; X 125.
Fig. 2. Photomicrographs of the tumor from Group 5 of the tumor
inhibition study which received only t'unor. Mitotic fig-
ures are numerous. Tumor cells are pleomorphic. Hematoxylin
and eosin; X 500.
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Fig. 2
EXPLANATION OF PLATE V
Fig. 1, Photomicrograph of a lung of a mouse from Group 5 of the
tumor Inhibition study which received only tumor. Foci of
metastasis by tumor cells. Hematoxylin and eosin; X 125.
Fig. 2. Photomicrograph of a lung of a mouse from Group 5 of the
tumor inhibition study which received only tumor. Metastasis
in the lung. Hematoxylin and eosin; X 300.
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PLATE V
Fig. 1
Fig. 2
EXPLANATION OF PLATE VI
Fig. 1. Photomicrograph of the liver of a mouse from tumor control
Group 5 of the tumor inhibition study which received only
tumor. Extension of the tumor into liver. Upper half is
liver; lower half is tumor, hematoxylin and eosin; X 125.
Fig. 2. Photomicrograph of the liver of a mouse from tumor control
Group 5 of the tumor inhibition study which received only
tumor. Xuuior cells in the liver by metastasis, hematoxylin
and eosin; X 500.
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PLATE VI
>«. ! v
Fig. 1
Fig. 2
EXPLANATION CF PLATE VII
Fig. 1. Photomicrograph of a tumor from Group 2 of the tumor inhibi-
tion study which received DEP-DA at a rate of 90 mg./kg.
Calcification in the degenerating tumor cells. Hematoxylin
and eoein; X 125.
Fig. 2. Photomicrograph of a tumor removed from CJi/Hej control
mouse after seven days of growth. Reticular fibres in the
viable areas of the tumor. Necrotic area is devoid of
reticular fibres. Wilder' I silver stain; X 125.
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PLATE VII
Fig. 1
Fig. 2
EXPLANATION OF PLATE VIII
Fig, 1. Photomicrograph of a uterus of a mouse in the toxicity
study which received DEP-DA at a rate of 46.6 mg./kg.
Endometrial hyperplasia. Hematoxylin and eosln; X 125*
Fig. 2. Photomicrograph of a uterus of a mouse from the toxicity
study which received DEP-DA at a rate of 96.5 mg./kg.
Endometrial hyperplasia. Hematoxylin and eosin; X 125.
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EXPLANATION OF PLATE IX
Fig. 1. Photomicrograph of a urinary bladder of a mouse from Group
2 of the tumor inhibition study which received DEP-DA at a
rate of 90 mg./kg. Epithelium has a tendency towards squamous
metaplasia. Hematoxylin and eosin; X 123.
Fig. 2. Photomicrograph of a uterus of a mouse from the toxicity
study which received DES-DA at a rate of 45.8 mg./kg.
Squamous metaplasia of the epithelium. Hematoxylin and
eosin} X 125.
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EXPLANATION OF PLATE X
Fig, 1, Photomicrographs of a tumor from second day of the patho-
genesis study. The site is that of tumor inoculation.
Tumor cells are intermingled with inflammatory cells.
Hematoxylin and eosin; X 125.
Fig, 2. Photomicrograph of a tumor from fourth day of the patho-
genesis study. Tumor cells are proliferating and infil-
trating into the subcutis. Hematoxylin and eosin; X 125.
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EXPLANATION OF PLATE XI
Fig. 1. Photomicrograph of a tumor from Group 2 of the tumor inhibi-
tion study which received DEP-DA at a rate of 90 mg./kg.
Necrotic areas evidenced by pyknosis, koryorrhexis and kar-
yolysis. Viable areas are also seen. Hematoxylin and eoain;
X 125.
Fig. 2. Photomicrograph of a turner from Group 2 of the tumor Inhibi-
tion study which received DEP-BA at a rate of 90 mg./kg.
Necrotic areas evidenced by pyknosis, karyorrhexls and kar-
yolysis. Viable areas are also seen. Hematoxylin and eosin;
X 125.
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PLATE XI
AN HISTOPATHOLOGIC STUDY OF TBI EFFECTS OF A SUBSTITUTED
PHENANTHRENE DERIVATIVE OS SARCOMA 37 IN MICE
B. Sc., Osmanla University, Hyderabad, India, 1955
B. V. Sc., A. H., Agricultural University (A. P.), Hyderabad, India, 1959
All ABSTRACT OF A MASTER'S THESIS
submitted in partial fulfillment of toe
requirements for the
Department of Pathology, Parasitology and Public Health
KANSAS STATE UNIVERSITY
1966
Treatment end control of cancer by surgical Intervention end irradiation
techniques he* been well established. The search for chemotherapeutic agents
with the seas efficacy has resulted in the finding of very few drugs which
have both antitumor properties and minimal side effects. The present study
represents a preliminary screening of another potential chemotherapeutic
The newly synthesized compound. 3,6-diacetate of 9,10-diethyi phenan-
threne <DKP-T>A), was studied for side effects end for its antitumor activity
on Sarcoma 37 in tumor-susceptible CLH/Hej mice. The compound (DEP-DA) was
prepared by ultraviolet irradiation of diethylstllbestrol dlacetate (DES-DA),
which alec was Included in the study for comparative purposes.
Preliminary studies were made with corn oil, olive oil and saline which
were the carriers in which the drug would later be administered. Each of
three groups of mice were injected with one of the above carriers and simi-
lar groups were kept as controls.
Toxicity studies were performed on four groups of CLH/Hej female mice.
The first and second group of mice received DEP-DA at a rate of 46.6 mg./kg.
and 96.5 mg./kg. respectively. The third group received DES-DA at a rate of
45.6 mg./kg. The mice of the fourth group received 0.2 ml. of corn oil only.
Five injections were made at daily intervals. The mice were sacrificed seven
days after the last injection for gross and microscopic evaluation.
Sarcoma 37 wee obtained from the Jackson Laboratory, Bar ilarbour, Maine,
in DBA/iJ mice and Immediately transplanted into C H/hej female mice which
used for tumor inhibition studies. The mice were weighed in groups to
determine the dosage of the compound to be tested. The first and
groups of mice received DEF-DA at a rate of 45 mg./kg. and 90 mg./kg.
respectively. The third group of mice received DES-DA et e rete of 36.6
mg./kg. The alee of the fourth group received 0.2 mi. of corn oil only end
the fifth group received no Injection other then the tumor.
In the pathogenesis studies alee received the drug from the fourth day
post tumor Injection. The mice were sacrificed at dally intervals for 26
days.
Mice from the toxicity, tumor inhibition and pathogenesis studies were
preserved in 102 formalin end the tissues were collected for histopathologic
examination after routine staining with hematoxylin and eoein. Special
•tains were employed where indicated.
Preliminary studies with the carriers revealed aicroscoptc.il ly a
granulomatous reaction In mice that received corn oil; however, this oil was
used in subsequent studies because the PEP-DA and OSS-DA were more soluble
in It.
In the toxicity studies the uteri were found to be enlarged both in
those mice receiving DSP-DA and those which received DKS-DA. With the former
drug only endometrial hyperplasia was ncted. with the latter compound
metaplasia was observed in addition to the endometrial hyperplasia,
wall of the urinary bladder was thickened due to increased lamina propria
sttbnucoea in both Instances.
In the tumor inhibition studies extensive areas of necrosis were seen
with DEP-DA, especially when employed at the higher level. Necrosis was
microscopically evidenced by pyknosis, karyorrhexis , karyolysls end calcifi-
cation. Mitotic figures were markedly reduced in the viable areas of the
tumor. The DKP-DA wee observed to set primarily by arresting mitoses. The
DES-DA wee found to cause comparable changes. Endometrial hyperplasia was
« consistent finding in these mice. The urinary bladder was very often
grossly thickened; microscopically squamous metaplasia of the epithelium mm
observed in several instances.
The most significant change observed in the pathogenesis studies in
which the mice were treated with a higher dose of DEP-DA, was that the tumor
developed necrotic areas as early as the sixth day, i.e., three days after
the first injaction of the drug. In contrast the untreated tumors took 10
days or more to develop necrotic areas in the normal course of their growth.
The 3,6-diacetate of 9,10-diethyi phenanthrene was shown to possess
antitumor activity principally evidenced by arresting mitoses in the tumor
cells. In spite of its estrogenic activity the new compound may prove to be
valuable on further investigations.
